SIGA
NASDAQ · Pharmaceuticals
Siga Technologies Inc
$4.28
-0.04 (-0.93%)
Financial Highlights (FY 2026)
Revenue
94.39M
Net Income
23.23M
Gross Margin
68.6%
Profit Margin
24.6%
Rev Growth
-5.1%
D/E Ratio
—
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 68.6% | 68.6% | 56.0% | 56.0% |
| Operating Margin | 25.1% | 22.6% | 29.0% | 30.7% |
| Profit Margin | 24.6% | 23.4% | 29.9% | 24.4% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 94.39M | 99.50M | 139.54M | 109.98M |
| Gross Profit | 64.74M | 68.25M | 78.20M | 61.63M |
| Operating Income | 23.65M | 22.44M | 40.44M | 33.76M |
| Net Income | 23.23M | 22.04M | 41.70M | 26.81M |
| Gross Margin | 68.6% | 68.6% | 56.0% | 56.0% |
| Operating Margin | 25.1% | 22.6% | 29.0% | 30.7% |
| Profit Margin | 24.6% | 23.4% | 29.9% | 24.4% |
| Rev Growth | -5.1% | -5.1% | +11.8% | -1.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 0 | 0 | 102.11M | 85.97M |
| Total Equity | — | — | 302.28M | 324.83M |
| D/E Ratio | — | — | 0.34 | 0.26 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 24.21M | 24.25M | 62.48M | 50.98M |
| Free Cash Flow | — | — | 48.98M | 38.86M |